News

  • 22 March 2019

    FDA approves Jazz Pharma’s sleep disorder drug Sunosi

    The US Food and Drug Administration has approved Ireland-based Jazz Pharmaceuticals’ Sunosi drug to treat adults suffering from excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea

Go Top